Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | SAbDab Target/Gene Name | Format | Order |
---|---|---|---|---|---|
Pre-Made Caplacizumab biosimilar, Nanobody, Anti-VWF Antibody: Anti-F8VWF/VWD therapeutic antibody |
Caplacizumab |
VWF |
Nanobody |
||
Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1, hPD-L1 therapeutic antibody |
Envafolimab |
PDL1 |
Single Domain Variable Fragment;H |
||
Pre-Made Letolizumab biosimilar, Single Domain Variable Fragment;H, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody |
Letolizumab |
CD40LG |
Single Domain Variable Fragment;H |
||
Pre-Made Lulizumab biosimilar, Single Domain Variable Fragment;L, Anti-CD28 Antibody: Anti-Tp44 therapeutic antibody |
Lulizumab |
CD28 |
Single Domain Variable Fragment;L |
||
Pre-Made Placulumab biosimilar, Single Domain Variable Fragment (VL + Fc), Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody |
Placulumab |
TNFA |
Single Domain Variable Fragment (VL) + Fc |
||
Pre-Made Rimteravimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Rimteravimab |
SARS-CoV-2 Spike RBD |
Mixed Nanobody (VHH-CH2-CH3 dimer) |
View the Knowledge base of Tandem VHH/ Nanobody(single domain antibody):
– Tandem VHH/Nanobody (single domain antibody): Structure, Production, Application and Products
– Tandem VHH/Nanobody (single domain antibody) – Introduction
– Structure and Physicochemical Features of Nanobody (single domain antibody)
– Nanobody (single domain antibody) production
– Application of nanobodies (single domain antibodies)
– Advantages and limitation of Nanobodies (single domain antibodies)
– GeneMedi’s products list of Nanobodies (single domain antibodies)